Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +61.61%
#3 DogBull DogBull +36.85%
#4 Ontology Gas Ontology Gas +32.12%
#5 BOOK OF MEME BOOK OF MEME +30.55%
#6 Neiro Neiro +22.27%
#7 Nockchain Nockchain +19.56%
#8 Pump.fun Pump.fun +18.85%
#9 Unit Pump Unit Pump +18.85%
#10 rsERG rsERG +18.40%
Coin of the day
Pleasing Gold Pleasing Gold
設定
言語
日本
通貨
USD
テーマ
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
株式のランク #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
株価
$0.12164306
最終同期: 2024-11-11
時価総額
$38.53M
変化（1日）
-4.14%
変化（1年）
0.00%
国
AU
取引 PharmAust Limited (PAA)

カテゴリー

Healthcare
PharmAust Limited（PAA）の配当履歴
PharmAust Limited（証券コード：PAA）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのPharmAust Limited（PAA）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH